Type 1 diabetes is caused by the destruction of insulin producing β cells by the immune system. Islet cell transplantation therapy represents a viable therapeutic approach for treating type 1 diabetes
Read More
Immune checkpoint blocking antibodies have gained great success in the clinic however, these treatments are effective for only about 30% of patients. Most of these antibodies block co-inhibitory molec
Read More
InVivoMAb anti-mouse IL-27 p28 is used for in vivo IL-27 p28 neutralization, in vitro IL-27 p28 neutralization, and Flow cytometry.
Read More
The Prouty is the signature event of The Friends of Norris Cotton Cancer Center whose mission is to raise money and awareness for this nationally recognized cancer facility. NCCC has 15 locations thro
Read More
Bio X Cell felt honored to co-host the 11th Annual Block Party in Lebanon, on Thursday, June 27th, 2019, to support the Norris Cotton Cancer Center and the Prouty!
Read More
The 5G4.6 monoclonal antibody reacts with the TNF family member TL1A, also known as TNFSF15. TL1A is expressed on activated T cells, dendritic cells, monocytes, and endothelial cells.
Read More
The combination of anti-PD-1 and anti-CTLA-4 antibody-mediated immunotherapy is remarkably effective against melanoma, renal cell carcinoma, and non-small-cell lung cancer.
Read More
The P84 monoclonal antibody reacts with Signal-Regulatory Protein α (SIRPα), also known as CD172a.
Read More
The 20D5 monoclonal antibody reacts with mouse NKG2A, NKG2C, and NKG2E also known as CD159a, CD159c, and CD159e respectively.
Read More